1 Min Read
Dec 14 (Reuters) - Recro Pharma Inc
* Broadfin Capital reports 16.43 percent stake in Recro Pharma as of Dec 13 versus 20.66 percent stake as of Aug 11 - SEC filing Source text: (bit.ly/2gM7A0V) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.